Osaic Holdings
GH icon

Osaic Holdings’s Guardant Health GH Stock Holding History

Osaic Holdings’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.95M Buy
46,323
+32,322
+231% +$3.52M 0.01% 1283
2026
Q1 		$1.29M Sell
14,001
-21,930
-61% -$2.2M ﹤0.01% 2465
2025
Q4 		$3.67M Buy
35,931
+11,305
+46% +$1.01M 0.01% 1611
2025
Q3 		$1.64M Sell
24,626
-4,935
-17% -$268K ﹤0.01% 2348
2025
Q2 		$1.54M Buy
29,561
+16,039
+119% +$716K ﹤0.01% 2137
2025
Q1 		$576K Sell
13,522
-4,087
-23% -$176K ﹤0.01% 2739
2024
Q4 		$538K Sell
17,609
-7,706
-30% -$217K ﹤0.01% 2731
2024
Q3 		$581K Buy
25,315
+22,491
+796% +$637K ﹤0.01% 2725
2024
Q2 		$81.5K Sell
2,824
-19,305
-87% -$450K ﹤0.01% 4294
2024
Q1 		$457K Buy
22,129
+13,876
+168% +$297K ﹤0.01% 3013
2023
Q4 		$223K Sell
8,253
-3,315
-29% -$87K ﹤0.01% 3830
2023
Q3 		$343K Buy
11,568
+2,532
+28% +$89K ﹤0.01% 3569
2023
Q2 		$324K Buy
9,036
+1,080
+14% +$31K ﹤0.01% 3518
2023
Q1 		$186K Buy
7,956
+182
+2% +$5.2K ﹤0.01% 3920
2022
Q4 		$211K Sell
7,774
-1,950
-20% -$89.2K ﹤0.01% 3796
2022
Q3 		$523K Buy
9,724
+929
+11% +$47.7K ﹤0.01% 2855
2022
Q2 		$355K Buy
8,795
+531
+6% +$26.3K ﹤0.01% 3270
2022
Q1 		$6.82M Sell
8,264
-1,123
-12% -$76.9K 0.01% 994
2021
Q4 		$939K Sell
9,387
-3,046
-24% -$315K ﹤0.01% 2466
2021
Q3 		$1.55M Buy
12,433
+76
+0.6% +$9.03K ﹤0.01% 1945
2021
Q2 		$1.53M Buy
12,357
+1,325
+12% +$178K ﹤0.01% 1954
2021
Q1 		$1.69M Sell
11,032
-707
-6% -$107K ﹤0.01% 1759
2020
Q4 		$1.51M Sell
11,739
-17,170
-59% -$1.98M ﹤0.01% 1676
2020
Q3 		$3.22M Buy
28,909
+18,137
+168% +$1.66M 0.01% 1013
2020
Q2 		$875K Sell
10,772
-37,679
-78% -$3.04M ﹤0.01% 1850
2020
Q1 		$1.14M Buy
+48,451
New +$3.72M ﹤0.01% 1446

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Osaic Holdings's GH Position: Q2 2026 in Review

Osaic Holdings increased its Guardant Health (GH) stake by 231% in Q2 2026, buying an estimated $3.52M and bringing the position to 46,323 shares worth $6.95M. The position accounts for 0.01% of the portfolio, ranked #1283.

Osaic Holdings first reported a position in GH in Q1 2020 and has held it in 26 quarters since. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Osaic Holdings held 46,323 shares of Guardant Health worth $6.95M as of Q2 2026.
  • Osaic Holdings bought 32,322 Guardant Health shares in Q2 2026, an estimated $3.52M.
  • Guardant Health made up 0.01% of Osaic Holdings's portfolio in Q2 2026, its #1283 holding.
  • Osaic Holdings first reported a position in Guardant Health in Q1 2020 and has held it in 26 quarters since.
  • 600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.